50 The clinical benefits, although statistically highly significant, were rather modest.
← all excerpts
A frameshift-generated cancer neoepitope that controls tumor burden in prophylaxis as well as therapy.
1
—
—
50 The clinical benefits, although statistically highly significant, were rather modest.